Indolent Adult Non-Hodgkin Lymphoma — Trials

Indolent Adult Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Barbara Ann Karmanos Cancer Institute
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04626739	CAR-T Cells in Treating Patients With Relapsed or Refractory NHL	unknown	Early Phase 1	100	Hebei Senlang Biotechnology Inc., Ltd.INDUSTRY	1	Nov 13, 2020	clinicaltrials

Data updated 23 days agoSource updated Nov 13, 2020source: clinicaltrials